Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents-Reference-Cited by-同舟云学术

Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents

Published:2021-01-21 Issue:4 Volume:34 Page:720-734
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Alhamar Mohamed^ORCID,Alkamachi Bassam,Mehrotra Harshita,Sanchez Jessica,Ali Haythem,Schultz Daniel,Chitale Dhananjay A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41379-020-00728-z.pdf

Reference28 articles.

1. Sneige N, Hess KR, Multani AS, Gong Y, Ibrahim NK. Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: a cohort study. Cancer. 2017;123:1115–23.

2. Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist. 2009;14:320–68.

3. Owens MA, Horten BC, Da Silva MM. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin Breast Cancer. 2004;5:63–9.

4. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997;15:2894–904.

5. Ballard M, Jalikis F, Krings G, Schmidt RA, Chen YY, Rendi MH, et al. ‘Non-classical’ HER2 FISH results in breast cancer: a multi-institutional study. Mod Pathol. 2017;30:227–35.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological Features and Long-Term Prognostic Role of Human Epidermal Growth Factor Receptor-2 Low Expression in Chinese Patients with Early Breast Cancer: A Single-Institution Study;BIOMED ENVIRON SCI;2024

2. Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns;Journal of Clinical Pathology;2024-02-12

3. Clinicopathological Features and Prognostic Role of HER2 Low in Early Breast Cancer: A Real World Study;2023-08-07

4. Invasive Breast Cancer with HER2 ≥4.0 and;Breast Cancer: Targets and Therapy;2023-08

5. Relationship between the changes of positivity rate of HER2 expression and the diameter of invasive lesions in early breast cancer and its clinical significance;Pathology - Research and Practice;2022-05